Fate Therapeutics (FATE) Restructuring Costs (2023)

Fate Therapeutics (FATE) has 1 years of Restructuring Costs data on file, last reported at $2.0 million in Q1 2023.

• Quarterly Restructuring Costs changed N/A year-over-year to $2.0 million in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $2.0 million (changed N/A YoY) and the FY2023 annual result came in at $2.0 million, changed N/A from the prior year.
• Restructuring Costs held at $2.0 million in Q1 2023.
• In the past five years, Restructuring Costs ranged from a high of $2.0 million in Q1 2023 to a low of $2.0 million in Q1 2023.